Cambium Bio (ASX: CMB) has received approval from the US Food and Drug Administration (FDA) for a protocol relating to Phase ...
Lode Resources (ASX: LDR) has identified a significant high-value opportunity along strike from its recently acquired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback